Cathie Wood’s ARK Invest Sells Over 140,000 More Shares of Pfizer
One of Cathie Wood's ARK Invest exchange-traded funds sold over 140,000 shares of Pfizer on November 10.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
A day after one ARK Invest exchange-traded fund run by ETF star Cathie Wood parted with more than $11 million worth of Pfizer Inc. (NYSE: PFE | PFE Price Prediction) shares, that fund was back at it on Wednesday. Specifically, it sold over 140,000 more shares, as the price of this ETF pulled back over 4% in the day’s session. However, it is up a fair amount in the past year.
[in-text-ad]
It was ARK Genomic Revolution ETF (NYSEARCA: ARKG) that shed 140,713 shares of Pfizer. At Wednesday’s closing price, this would have valued this sale at roughly $6.9 million. This is only a small fraction of the total holdings. The fund is up about 7% over the past 52 weeks.
Check out all the ARK Invest sales for Wednesday:
| Fund | Ticker | Name | Shares |
|---|---|---|---|
| ARKG | CLLS | CELLECTIS | 8,300 |
| ARKG | PFE | PFIZER | 140,713 |
| ARKG | REGN | REGENERON PHARMACEUTICALS | 11,602 |
| ARKK | U | UNITY SOFTWARE | 113,490 |
| ARKQ | U | UNITY SOFTWARE | 15,700 |
| ARKW | U | UNITY SOFTWARE | 28,889 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of 247wallst.com.
[recirclink id=989840][wallst_email_signup]
Contact [email protected] for any questions or corrections.







